MySubsidy

Medical Device Clinical Studies Support Scheme (MDCSSS) - SMDI

Department of Pharmaceuticals · Central government

The scheme provides reimbursement grants of up to ₹5 crore to Indian manufacturers of medical devices and IVDs for clinical studies.

Closed. Applications closed on 24 July 2026. The details below describe the most recent cycle.

Key facts

Subsidy amount
Up to ₹5,00,00,000
Instrument
Subsidy
Deadline
24 July 2026
Disbursement
Reimbursed after spend
Scheme duration
3 years

About this scheme

The Medical Device Clinical Studies Support Scheme (MDCSSS) forms part of the Scheme for Strengthening of Medical Device Industry (SMDI), which the Department of Pharmaceuticals, Ministry of Chemicals & Fertilizers, Government of India, has launched. Its purpose is to strengthen India's medical device manufacturing sector by encouraging the development of high-quality devices supported by rigorous clinical evidence.

MDCSSS seeks to encourage the generation of clinical data needed to show that medical devices and In-Vitro Diagnostics (IVDs) developed and manufactured in India are safe and effective. Support is given on a reimbursement basis, which lowers the financial burden on manufacturers and allows them to carry out pre-clinical animal studies, clinical investigations, post-market clinical follow-up and IVD performance evaluations.

The scheme matters for building credibility and market acceptance of 'Made in India' medical devices, both within India and abroad. It promotes innovation and adherence to global regulatory standards, and so contributes to a self-reliant and robust medical device ecosystem in the country. Established manufacturers, IVD companies, institutes of national importance and startups based in incubation centres affiliated with such institutions are all eligible to apply.

Who can apply

Eligible business forms
Private limited company, Limited liability partnership, One person company, Partnership firm, Sole proprietorship
Udyam registration
Not specified
MSME registration
Not specified
DPIIT startup recognition
Not specified
GST registration
Not specified
Where the business may be based
Not restricted

- Manufacturers of medical devices and IVDs that operate a manufacturing facility in India. - Institutes of national importance (NIPERs, IISER, IITs, AIIMS, IISc) and other Central Institutes/Laboratories. - Startups based in incubation centres under these institutes, which may apply through the institute. - Applicants holding valid regulatory permissions relevant to their study type (Test License, CI Permission, IVD PE Permission, PMCF approval under Medical Devices Rules 2017). - Studies conducted within India. - Applicants providing co-financing, since funding is on a reimbursement basis and covers a percentage of total expenditure.

How to apply

1. **Access the SMDI portal:** Go to the official application portal at https://smdi.lsssdc.in/. 2. **Fill in the application form:** Provide all required details in the online form, covering your organisation, the proposed study and how it meets the eligibility criteria. 3. **Upload the required documents:** Attach the necessary paperwork, including proof of a manufacturing facility in India, valid regulatory permissions (Test License, CI Permission, IVD PE Permission, PMCF approval under Medical Devices Rules 2017), detailed study protocols, project budgets and company financials. 4. **Submit the application:** Send your completed application before the specified deadline. 5. **Review and selection:** Applications go through a selection process that involves appraisal by the Project Management Agency (PMA), review by a Technical Committee and final approval by the Scheme Steering Committee. 6. **After selection:** If selected, carry out your clinical study. Funding is disbursed on a reimbursement basis once the study is completed, results are verified and findings are published.

Apply on the issuer's sitesupport-smdi@lsssdc.in

How applications are assessed

Applications are first appraised by the Project Management Agency (PMA). A dedicated Technical Committee then reviews the proposals, assessing scientific merit, feasibility and the potential impact of the clinical studies. Final approval rests with the Scheme Steering Committee, which confirms that projects align with the wider objectives of the SMDI scheme and the Department of Pharmaceuticals.

Throughout, the emphasis is on sound clinical methodology and relevance to the Indian medical device landscape.

Frequently asked questions

What is the primary objective of the MDCSSS scheme?

The scheme's main aim is to help the medical device industry develop devices supported by clinical evidence and to generate clinical data demonstrating their safety and efficacy.

Who is eligible to apply for this scheme?

Medical device and IVD manufacturers with facilities in India, institutes of national importance (NIPERs, IISER, IITs, AIIMS, IISc), other Central Institutes/Laboratories, and startups in incubation centres under these institutes (applying through the institute) are eligible to apply.

What types of studies are eligible for funding?

The scheme funds Pre-Clinical Animal Studies, Clinical Investigations, Post-Market Clinical Follow-up (PMCF) and IVD Performance Evaluation.

What is the maximum funding available?

Funding of up to ₹5 crore is available for clinical investigations, or up to 70% of expenditure for companies whose average turnover is ₹10 crore or less.

How is the funding disbursed?

Funding is released only as reimbursement, once the study is complete, its results have been verified and the findings published.

Are there any geographical restrictions for the studies?

Yes. Eligible studies have to be carried out in India, and applicants must hold a manufacturing facility located in India.

Sectors

  • Health Lifesciences
  • Medical Devices
  • Clinical Studies
  • Healthcare
  • Ivd
  • Manufacturing
  • Biotechnology
  • Reimbursement

Details last verified on 12 November 2026. Source: the issuer's published information.